Direktorat Registrasi ObatValid

LAMIVUDINE

Claim this product
BPOM Number
GKL2133553117A1
Approved
21 November 2024
Expiry
31 January 2028
Form
TABLET SALUT SELAPUT; 150 MG

About This Registration

LAMIVUDINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2133553117A1. Its current registration status is Valid, with the licence valid until 31 January 2028. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in January 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 BOTOL PLASTIK @ 60 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

LAMIVUDINE

Market Intelligence

Owner Portfolio
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Registration Age
Registered for 3 years, 7 months

FDA Cross-Reference

via openFDA
Generic Name
LAMIVUDINE AND ZIDOVUDINE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1